Lyotropic Therapeutics, a privately-owned specialty pharma company formed in 1999, recently completed the sale of its advanced products and technology

Lyotropic Therapeutics operated from 1999 to late 2011, during which time it developed and sold a basket of pharmaceutical products in pain and anesthesia, and subsequently transferred the company's proprietary technologies to a respected CRO specializing in formulation development. The technologies are broadly applicable for small molecule APIs and biopharmaceuticals that are: ▫ Difficult to solublize ▫ Unstable ▫ Poorly absorbed ▫ Efflux/P-gp substrates ▫ Requiring sustained release...

Lyotropic Therapeutics operated from 1999 to late 2011, during which time it developed and sold a basket of pharmaceutical products in pain and anesthesia, and subsequently transferred the company's proprietary technologies to a respected CRO specializing in formulation development. The technologies are broadly applicable for small molecule APIs and biopharmaceuticals that are: ▫ Difficult to solublize ▫ Unstable ▫ Poorly absorbed ▫ Efflux/P-gp substrates ▫ Requiring sustained release Look for upcoming press releases announcing product launches and technology placement.